ALS should not be considered a neuromuscular disorder
Host: Giancarlo Logroscino, Italy Yes: Michael van Es, The Netherlands No: Monica Povedano Panades, Spain Patients should set the agenda for therapeutic trials in ALS
Host: Albert Ludolph, Germany Yes: Paul Wicks, USA The study of mice has been detrimental to developing therapy for ALS
Host: Kevin Talbot, UK Yes: Peter Bede, Ireland No: Elizabeth Fisher, UK
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. OkPrivacy policy